The Hill Mylan CEO Should be Ashamed of EpiPen Prices By Congressman Glenn Grothman (R-Wis.) Last week the House Oversight and Government Reform Committee held a hearing on the skyrocketing price of life-saving Epinephrine Auto-Injectors, better known as the EpiPen. This hearing was especially important because EpiPens are predominantly used to keep children alive, which makes accessibility imperative. During the hearing, I and other members of the committee questioned Heather Bresch, CEO of Myl... Read more